How systemic inflammatory diseases affect the lung

M. Kreuter (Heidelberg, Germany)

Source: Virtual Congress 2020 – Interstitial lung diseases
Session: Interstitial lung diseases
Session type: State of the art session
Number: 5061
Disease area: Interstitial lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany). How systemic inflammatory diseases affect the lung. Virtual Congress 2020 – Interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016

Systemic diseases involving the lung
Source: Breathe, 16 (4) 200282; 10.1183/20734735.0282-2020
Year: 2020



Characteristics of inflammatory bowel diseases-associated interstitial lung diseases
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011


Inflammatory bowel diseases, chronic liver diseases and the lung
Source: Eur Respir J 2016; 47: 638-650
Year: 2016



COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011


The impact of corticosteroid on the inflammatory mediators in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007


Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Year: 2021



Targeting TNF-alpha in inflammatory lung diseases
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005


Comparison of the inflammatory response between two chronic models of allergic lung inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 368s
Year: 2007

Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD)
Source: Eur Respir J 2007; 30: Suppl. 51, 110s
Year: 2007

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Diffuse parenchymal lung inflammation response in patients with inflammatory bowel disease
Source: Eur Respir J 2005; 26: Suppl. 49, 540s
Year: 2005

COPD: inflammatory mechanisms and systemic consequences
Source: Eur Respir Mon 2013; 59: 13-27
Year: 2013


Increased incidence of inflammatory bowel disease in Québec residents with airway diseases
Source: Eur Respir J 2015; 45: 962-968
Year: 2015